H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure. Census population 159,732. New Jersey Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Paterson clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Paterson storefront.
Pressure Ulcer Treatment Solutions in Paterson, NJ for clinics & physicians. Advanced pressure ulcer treat… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of pressure ulcer treatment in Paterson: (1) CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure. (2) New Jersey Part B wound biologics are reviewed by Novitas Solutions under JL, shared with DC, DE, MD, PA. We help with the second file. We do not pretend to be a Paterson storefront.
National Pressure Ulcer Treatment Solutions notes (how the product actually works)Three grains, kept separate on purpose. City: Census 159,732 and CDC PLACES crude rates. State: New Jersey Department of Health, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and Novitas Solutions LCDs. CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Paterson trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 16.1% of adults — 4.1 points above the U.S. 12% figure. Obesity is 37.5%; arthritis is 20%. That is place-level BRFSS modeling, not a clinic census and not a Paterson trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including New Jersey.
It is the Census city-proper count — useful as scale for a city under 250k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
New Jersey is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in Paterson, NJ.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Paterson is JL geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Paterson — 4.1 points above the U.S. 12% figure. Planning input, not an outcomes claim.
New Jersey Part B wound biologics follow this contractor (siblings: DC, DE, MD, PA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Paterson. Useful for joint-program math; still needs a diagnosis and privileging.
No Paterson storefront. Joe Bradley is an active practice owner. pressure ulcer treatment stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.